Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Y Wen

Showing results (11-20 of 639) with videos related to

Pageof 64
Sort By:
Current Opinion in Neurology|November 5, 2024
Progress in treatment of gliomasPatrick Y Wen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathyPatrick Y Wen
F1000 Medicine Reports|October 16, 2010
New therapies for recurrent glioblastomasPatrick Y Wen
Neuro-Oncology|July 16, 2014
Point/counterpoint: is there a role for radiotherapy in the treatment of primary CNS lymphoma?Patrick Y Wen
Neuro-Oncology|December 30, 2016
Message from the Editor-in-ChiefPatrick Y Wen
Current Neurology and Neuroscience Reports|September 21, 2021
Medical and Neurological Management of Brain Tumor ComplicationsGilbert Youssef, Patrick Y Wen
Neuro-Oncology|July 28, 2023
Advanced molecular diagnostic tools: A step closer to precision medicine in neuro-oncologyElisa Aquilanti, Patrick Y Wen
Neurology|April 15, 2014
Bevacizumab for glioblastoma: what can we learn from patterns of progression?Patrick Y Wen, Larry Junck
Current Neurology and Neuroscience Reports|April 23, 2004
Malignant gliomasPatrick Y Wen, Santosh Kesari
Current Opinion in Neurology|November 16, 2004
Non-cytotoxic drugs as potential treatments for gliomasJan Drappatz, Patrick Y Wen
Pageof 64

Showing results (11-20 of 639) with videos related to

Sort By:
Pageof 64
Current Opinion in Neurology|November 5, 2024
Progress in treatment of gliomasPatrick Y Wen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathyPatrick Y Wen
F1000 Medicine Reports|October 16, 2010
New therapies for recurrent glioblastomasPatrick Y Wen
Neuro-Oncology|July 16, 2014
Point/counterpoint: is there a role for radiotherapy in the treatment of primary CNS lymphoma?Patrick Y Wen
Neuro-Oncology|December 30, 2016
Message from the Editor-in-ChiefPatrick Y Wen
Current Neurology and Neuroscience Reports|September 21, 2021
Medical and Neurological Management of Brain Tumor ComplicationsGilbert Youssef, Patrick Y Wen
Neuro-Oncology|July 28, 2023
Advanced molecular diagnostic tools: A step closer to precision medicine in neuro-oncologyElisa Aquilanti, Patrick Y Wen
Neurology|April 15, 2014
Bevacizumab for glioblastoma: what can we learn from patterns of progression?Patrick Y Wen, Larry Junck
Current Neurology and Neuroscience Reports|April 23, 2004
Malignant gliomasPatrick Y Wen, Santosh Kesari
Current Opinion in Neurology|November 16, 2004
Non-cytotoxic drugs as potential treatments for gliomasJan Drappatz, Patrick Y Wen
Pageof 64